All studies
RecruitingPHASE1, PHASE2INTERVENTIONAL

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Sickle cell disease is an inherited blood condition that can cause severe bouts of pain and anaemia. This study looks at an experimental medicine called BMS-986470. Researchers want to find out how safe the medicine is, how it moves through the body, and whether it could help reduce painful sickle cell episodes. The trial involves two main groups. First, healthy adult volunteers will take the medicine so researchers can check safety and see if food or common heartburn tablets affect absorption. Second, adults living with sickle cell disease who have frequent pain crises will take the study drug or a dummy pill (placebo). Taking part involves regular health reviews, blood tests, and clinic visits. This early-stage research is an essential step towards finding new treatments that may one day improve health and reduce hospital visits for people living with sickle cell disease.

At a glance

Status
Recruiting
Phase
PHASE1, PHASE2
Sponsor
Bristol-Myers Squibb
Enrolment target
224
Start
17 Jul 2024
Estimated completion
16 Nov 2027

What is this study about?

Sickle cell disease is a lifelong genetic condition that affects red blood cells. Normally, red blood cells are round and flexible, allowing them to glide easily through blood vessels. In people with sickle cell disease, these cells can become hard and crescent-shaped. These rigid cells can get stuck in small blood vessels, blocking blood flow. This causes sudden, severe pain episodes known as vaso-occlusive crises, as well as fatigue and potential long-term damage to organs.

This clinical study is investigating a new tablet called BMS-986470. The primary goal is to find out if the drug is safe, how well the human body tolerates it, and how it is broken down. In the first stage, healthy volunteers will take the drug so doctors can observe how it behaves in the body and whether taking it with meals or standard antacid medicines changes how well it is absorbed.

In the next stage, the medicine will be given to adults who have sickle cell disease. Researchers want to observe whether BMS-986470 can help reduce the number of painful crises people experience and improve overall red blood cell health. Some participants may receive a placebo—a lookalike dummy pill with no active medicine—which helps doctors accurately compare the results.

Because this is an early-phase trial (Phase 1 and 2), the drug is not yet an approved treatment. However, well-monitored studies like this are crucial for creating newer, more effective treatment options for sickle cell disease in the future.

Key takeaways

  • The trial tests an experimental medicine (BMS-986470) designed to help treat sickle cell disease.
  • It is recruiting healthy adult volunteers and adults living with sickle cell disease.
  • Researchers are testing the drug's safety, absorption, and potential to reduce painful crises.
  • Participation involves clinic visits, blood tests, health checks, and possible short clinic stays.
  • Joining is completely voluntary, and you may leave the study at any time.

Who may be eligible?

This study is open to adults aged 18 and older, divided into two distinct groups. The first group is for healthy volunteers. To join this group, you must be in good general health, have a body mass index (BMI) between 18 and 32, and have no major health problems. Women joining the healthy group must not be able to have children (for instance, those who have gone through the menopause or had specific surgery).

The second group is for adults who have a confirmed medical diagnosis of sickle cell disease (such as HbSS or sickle beta-thalassaemia). To be considered, you must have experienced between 2 and 15 painful sickle cell crises over the past year that needed medical treatment. You must also be generally active and able to carry out daily tasks.

You will not be able to join the study if you have severe organ damage, recent major surgery, or blood test results that fall outside the trial's safety limits. A study doctor will run full health checks before confirming whether you can take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you aged 18 or older?
  2. Are you in good general health, OR do you have a confirmed diagnosis of sickle cell disease?
  3. If you have sickle cell, have you had at least 2 painful crises in the past year?
  4. Are you willing and able to attend clinic appointments and have regular blood tests?
  5. If female and in the healthy volunteer group, are you post-menopausal or unable to have children?
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will first attend a screening visit. The team will ask about your medical history, carry out a physical examination, take blood samples, and perform heart traces (ECGs) to make sure it is safe for you to join. Depending on your group, you will take either BMS-986470, a placebo, or the study drug combined with common heartburn tablets to test how it is absorbed. You will need to attend regular clinic visits for blood tests and health check-ups. Some stages of the study may require a short overnight stay in a specialist clinic for close monitoring. The overall length of your participation will depend on which part of the study you join, but it typically lasts several weeks to months, followed by a final safety review.

Potential risks and benefits

Taking part might not improve your personal health, particularly if you are in the healthy volunteer group or receive a placebo. However, your involvement will help doctors learn more about potential new therapies for sickle cell disease. As with any experimental medicine, there is a risk of unwanted side effects, which the medical team will explain in detail before you start. You will be monitored closely throughout the study, and emergency care is always available if needed. Taking part is completely voluntary, and you are free to leave the trial at any time without affecting your standard NHS care.

Locations (32)

  • University of Alabama at Birmingham
    Verified postcode
    Birmingham, United States· Recruiting
  • University of California San Diego - La Jolla
    Verified postcode
    La Jolla, United States· Recruiting
  • UCSF Benioff Children's Hospital Oakland
    Verified postcode
    Oakland, United States· Recruiting
  • Yale-New Haven Hospital
    Verified postcode
    New Haven, United States· Recruiting
  • Winship Cancer Institute of Emory University
    Verified postcode
    Atlanta, United States· Recruiting
  • Local Institution - 0034
    Verified postcode
    Chicago, United States· Not yet recruiting
  • Local Institution - 0001
    Verified postcode
    Lenexa, United States· Active not recruiting
  • Local Institution - 0064
    Verified postcode
    Baltimore, United States· Not yet recruiting
  • Local Institution - 0024
    Verified postcode
    Boston, United States· Not yet recruiting
  • Boston Medical Center
    Verified postcode
    Boston, United States· Recruiting
  • Local Institution - 0030
    Verified postcode
    St Louis, United States· Not yet recruiting
  • Local Institution - 0033
    Verified postcode
    Greenville, United States· Not yet recruiting

Common questions

What is a placebo?

A placebo is a dummy treatment that looks and tastes identical to the real medicine but contains no active drug. It allows doctors to see if health changes are genuinely caused by the medicine being tested.

Will taking part cost me anything?

No, the study medicine and all trial-related tests are provided free of charge. Travel expenses are usually reimbursed, and healthy volunteers often receive compensation for their time.

Can I carry on taking my usual sickle cell medication?

Many participants can continue standard treatments like hydroxyurea, provided the dose has been stable for some time. The study doctor will check all your regular medicines to ensure they are safe to use together.

Do I have to stay overnight in hospital?

Some stages of this early study may require one or more overnight stays in a research clinic. This is so doctors can take timed blood tests and monitor your body's response safely.

Can I leave the study if I change my mind?

Yes. You have the right to withdraw from the trial at any point, for any reason, without it affecting your normal medical care or your relationship with your doctors.

How to find out more

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A Study to Evaluate BMS-986470 in Healthy Volunteers and Par…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.